Citation only
via OpenAlex
Sulfhydrated Sirtuin-1 Increasing Its Deacetylation Activity Is an Essential Epigenetics Mechanism of Anti-Atherogenesis by Hydrogen Sulfide
Congkuo Du, Xianjuan Lin, Wenjing Xu, Fengjiao Zheng, Junyan Cai, Jichun Yang, Qinghua Cui, Chaoshu Tang, Jun Cai, Guoheng Xu, Bin Geng
Antioxidants and Redox Signaling · 2018 · ▲ 147 citations
Abstract
Aims: Hydrogen sulfide (H2S) has a protective role in the pathogenesis of atherosclerosis by multiple pathways. Sirtuin-1 (SIRT1) is a histone deacetylase, as an essential mediated longevity gene, and has an anti-atherogenic effect by regulating the acetylation of some functional proteins. Whether SIRT1 is involved in protecting H2S in atherosclerosis and its mechanism remains unclear. Results: In ApoE-knockout atherosclerosis mice, treatment with an H2S donor (NaHS or GYY4137) reduced atherosclerotic plaque area, macrophage infiltration, aortic inflammation, and plasma lipid level. H2S treatment increased aorta and liver SIRT1 mRNA expression. Overexpression or slicing cystathionine gamma lyase (CSE) also changed intracellular SIRT1 expression. CSE/H2S treatment increased SIRT1 deacetylation in endothelium and hepatocytes and macrophages, then induced deacetylation of its target proteins (P53, P65, and sterol response element binding protein), thereby reducing endothelial and macrophage inflammation and inhibiting macrophage cholesterol uptake and cholesterol de novo synthesis of liver. Also, CSE/H2S induced SIRT1 sulfhydration at its two zinc finger domains, increased its zinc ion binding activity to stabilize the alpha-helix structure, lowered its ubiquitination, and reduced its degradation. Innovation: H2S is a novel SIRT1 activator by direct sulfhydration. Because SIRT1 has a role in longevity, H2S may be a protector for aging-related diseases. Conclusion: Endogenous CSE/H2S directly sulfhydrated SIRT1, enhanced SIRT1 binding to zinc ion, then promoted its deacetylation activity, and increased SIRT1 stability, thus reducing atherosclerotic plaque formation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1089/ars.2017.7195
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Du, C., Lin, X., Xu, W., Zheng, F., Cai, J., Yang, J., Cui, Q., Tang, C., Cai, J., Xu, G., & Geng, B. (2018). Sulfhydrated Sirtuin-1 Increasing Its Deacetylation Activity Is an Essential Epigenetics Mechanism of Anti-Atherogenesis by Hydrogen Sulfide. <em>Antioxidants and Redox Signaling</em>. https://doi.org/10.1089/ars.2017.7195
Vancouver
Du C, Lin X, Xu W, Zheng F, Cai J, Yang J, et al. Sulfhydrated Sirtuin-1 Increasing Its Deacetylation Activity Is an Essential Epigenetics Mechanism of Anti-Atherogenesis by Hydrogen Sulfide. Antioxidants and Redox Signaling. 2018. doi:10.1089/ars.2017.7195.
BibTeX
@article{congkuo2018Sulfhy,
title = {Sulfhydrated Sirtuin-1 Increasing Its Deacetylation Activity Is an Essential Epigenetics Mechanism of Anti-Atherogenesis by Hydrogen Sulfide},
author = {Congkuo Du and Xianjuan Lin and Wenjing Xu and Fengjiao Zheng and Junyan Cai and Jichun Yang and Qinghua Cui and Chaoshu Tang and Jun Cai and Guoheng Xu and Bin Geng},
journal = {Antioxidants and Redox Signaling},
year = {2018},
doi = {10.1089/ars.2017.7195},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Clinical and Experimental Research 2019
Citation only
The Frailty Index in centenarians and their offspring
Endocrinology 2010
Open access · OA
Lack of SIRT1 (Mammalian Sirtuin 1) Activity Leads to Liver Steatosis in the SIRT1+/− Mice: A Role of Lipid Mobilization and Inflammation
生物医学与环境科学:英文版 2009
Citation only
Telomerase Activity and Telomerase Reverse Transcriptase Expression Induced by Selenium in Rat Hepatocytes
Atherosclerosis 2017
Preprint · CC-BY
Atherosclerosis in frailty: Not frailty in atherosclerosis
Aging and Disease 2020
Open access · CC-BY
Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia
Hepatic Medicine Evidence and Research 2016
Open access · CC-BY